Pdt Partners, LLC Iovance Biotherapeutics, Inc. Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $55,947 - $99,550	9,955 Added 4.81%	216,880 $1.39 Million
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $1.82 Million - $2.51 Million	191,276 Added 1222.29%	206,925 $1.98 Million
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $99,840 - $286,846	15,649 New	15,649 $173,000
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $278,099 - $563,182	-17,030 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $488,250 - $895,607	17,030 New	17,030 $539,000

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.